Progenics Pharmaceuticals, Inc. (PGNX) was a big mover last session with its shares rising nearly 16% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the trend of the company since Jan 15, as the stock is now down over 22%.
This biotechnology company has seen no estimate revision in the last 60 days. However, the Zacks Consensus Estimate has moved higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if yesterday’s rally can turn into more strength down the road.
Progenics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked BioMed stocks worth considering are Affymetrix Inc. (AFFX), Actelion Ltd. (ALIOF) and Gentium S.p.A (GENT). All these stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
PROGENICS PHARMA INC (PGNX): Free Stock Analysis Report
AFFYMETRIX INC (AFFX): Free Stock Analysis Report
ACTELION LTD (ALIOF): Free Stock Analysis Report
GENTIUM SPA GENTIUM SPA ADS ADSS (GENT): Free Stock Analysis Report
Zacks Investment Research
- Personal Investing Ideas & Strategies
- Finance Trading